Brevibloc Premixed 10 mg/ml Solution for Injection

*
Pharmacy Only: Prescription
  • Company:

    Baxter Holding B.V.
  • Status:

    No Recent Update
  • Legal Category:

    Product subject to medical prescription which may not be renewed (A)
  • Active Ingredient(s):

    *Additional information is available within the SPC or upon request to the company

Updated on 02 August 2023

File name

BE-30-03-279_17JUL19_P02 Brev Injection.pdf

Reasons for updating

  • New PIL for new product

Updated on 23 January 2023

File name

ie-spc-2019-03-brevibloc-inj-PA2299021001.pdf

Reasons for updating

  • Document format updated

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 04 April 2019

File name

ie-spc-2019-03-brevibloc-inj-PA2299021001.pdf

Reasons for updating

  • Change to section 7 - Marketing authorisation holder
  • Change to section 8 - Marketing authorisation number(s)
  • Change to section 10 - Date of revision of the text

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 31 July 2018

File name

Brevibloc Injection-PA167099003-c.pdf

Reasons for updating

  • Change to section 4.1 - Therapeutic indications
  • Change to section 4.2 - Posology and method of administration
  • Change to section 5.2 - Pharmacokinetic properties
  • Change to section 10 - Date of revision of the text

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 01 September 2016

Reasons for updating

  • New SPC for new product

Legal category:Product subject to medical prescription which may not be renewed (A)